1 gen 2011 anni - New event

Descrizione:

The first-in-class gene therapy drug, pCMV-vegf165, is registered in Russia for the treatment of peripheral artery disease, including the advanced stage of critical limb ischemia. The United Nations declaration on non-communicable diseases (NCD's) changes the global approach to these diseases, of which cardiovascular disease is the greatest contributor.

Aggiunto al nastro di tempo:

Data: